These biomimetic nanoparticles actively targeted homologous 4T1 tumors, enabled precise tumor targeting, and eliminated primary tumors by multiple imaging-guided PTT/SDT treatment, exposing tumor antigens, and enhancing immune responses by boosting CD8+ T cells and reducing Tregs. Here, CD8A is linked to neoplasm.